Читать книгу - "Живи долго! Научный подход к долгой молодости и здоровью - Майкл Грегер"

Ethnopharmacol. 2017;195:1–9. https://pubmed.ncbi.nlm.nih.gov/27940086/

5306

Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2009;(1):CD003120. https://pubmed.ncbi.nlm.nih.gov/17443523/

5307

Wang Y, Yang G, Gong J, et al. Ginseng for Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials. Curr Top Med Chem. 2015;16(5):529–36. https://pubmed.ncbi.nlm.nih.gov/26268331/

5308

Shakespeare W. The Tragedy of Hamlet, Prince of Denmark. Act IV, scene 5, line 3053. OpenSourceShakespeare. https://www.opensourceshakespeare.org/views/plays/play_view.php?WorkID=hamlet&Act=4&Scene=5&Scope=scene. Published 1786. Accessed July 1, 2022.; https://www.opensourceshakespeare.org/views/plays/play_view.php?WorkID=hamlet&Act=4&Scene=5&Scope=scene

5309

Perry EK, Pickering AT, Wang WW, Houghton PJ, Perry NS. Medicinal plants and Alzheimer’s disease: from ethnobotany to phytotherapy. J Pharm Pharmacol. 1999;51(5):527–34. https://pubmed.ncbi.nlm.nih.gov/10411211/

5310

Moss M, Cook J, Wesnes K, Duckett P. Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. Int J Neurosci. 2003;113(1):15–38. https://pubmed.ncbi.nlm.nih.gov/12690999/

5311

Moss M, Oliver L. Plasma 1,8-cineole correlates with cognitive performance following exposure to rosemary essential oil aroma. Ther Adv Psychopharmacol. 2012;2(3):103–13. https://pubmed.ncbi.nlm.nih.gov/23983963/

5312

Pengelly A, Snow J, Mills SY, Scholey A, Wesnes K, Butler LR. Short-term study on the effects of rosemary on cognitive function in an elderly population. J Med Food. 2012;15(1):10–7. https://pubmed.ncbi.nlm.nih.gov/21877951/

5313

Shinjyo N, Green J. Are sage, rosemary and lemon balm effective interventions in dementia? A narrative review of the clinical evidence. Eur J Integr Med. 2017;15:83–96. https://www.sciencedirect.com/science/article/abs/pii/S187638201730149X

5314

Kennedy DO, Wake G, Savelev S, et al. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology. 2003;28(10):1871–81. https://pubmed.ncbi.nlm.nih.gov/12062586/

5315

Perry NSL, Menzies R, Hodgson F, et al. A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of age. Phytomedicine. 2018;39:42–8. https://pubmed.ncbi.nlm.nih.gov/29433682/

5316

Moss M, Cook J, Wesnes K, Duckett P. Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. Int J Neurosci. 2003;113(1):15–38. https://pubmed.ncbi.nlm.nih.gov/12690999/

5317

Jimbo D, Kimura Y, Taniguchi M, Inoue M, Urakami K. Effect of aromatherapy on patients with Alzheimer’s disease. Psychogeriatrics. 2009;9(4):173–9. https://pubmed.ncbi.nlm.nih.gov/20377818/

5318

Eriksson PS. Neurogenesis and its implications for regeneration in the adult brain. J Rehabil Med. 2003;(41 Suppl):17–9. https://pubmed.ncbi.nlm.nih.gov/12817652/

5319

Eriksson PS, Perfilieva E, Björk-Eriksson T, et al. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4(11):1313–7. https://pubmed.ncbi.nlm.nih.gov/9809557/

5320

Take comfort in human neurogenesis. Nat Med. 1998;4(11):1207. https://pubmed.ncbi.nlm.nih.gov/9809518/

5321

Jimbo D, Kimura Y, Taniguchi M, Inoue M, Urakami K. Effect of aromatherapy on patients with Alzheimer’s disease. Psychogeriatrics. 2009;9(4):173–9. https://pubmed.ncbi.nlm.nih.gov/20377818/

5322

Aydin Yildirim T, Kitis Y. The effect of aromatherapy application on cognitive functions and daytime sleepiness in older adults living in a nursing home. Holist Nurs Pract. 2020;34(2):83–90. https://pubmed.ncbi.nlm.nih.gov/32049695/

5323

Ayaz M, Sadiq A, Junaid M, Ullah F, Subhan F, Ahmed J. Neuroprotective and anti-aging potentials of essential oils from aromatic and medicinal plants. Front Aging Neurosci. 2017;9:168. https://pubmed.ncbi.nlm.nih.gov/28611658/

5324

Zalomonson S, Freud T, Punchik B, Samson T, Lebedinsky S, Press Y. The results of a crossover placebo-controlled study of the effect of lavender oil on behavioral and psychological symptoms of dementia. Rejuvenation Res. 2019;22(3):246–53. https://pubmed.ncbi.nlm.nih.gov/30328781/

5325

Ball EL, Owen-Booth B, Gray A, Shenkin SD, Hewitt J, McCleery J. Aromatherapy for dementia. Cochrane Database Syst Rev. 2020;2020(8):CD003150. https://pubmed.ncbi.nlm.nih.gov/32813272/

5326

Burns A, Perry E, Holmes C, et al. A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2011;31(2):158–64. https://pubmed.ncbi.nlm.nih.gov/21335973/

5327

Watson K, Hatcher D, Good A. A randomised controlled trial of lavender (Lavandula angustifolia) and lemon balm (Melissa officinalis) essential oils for the treatment of agitated behaviour in older people with and without dementia. Complement Ther Med. 2019;42:366–73. https://pubmed.ncbi.nlm.nih.gov/30670268/

5328

Hishikawa N, Takahashi Y, Amakusa Y, et al. Effects of turmeric on Alzheimer’s disease with behavioral and psychological symptoms of dementia. Ayu. 2012;33(4):499–504. https://pubmed.ncbi.nlm.nih.gov/23723666/

5329

Zhu LN, Mei X, Zhang ZG, Xie YP, Lang F. Curcumin intervention for cognitive function in different types of people: a systematic review and meta-analysis. Phytother Res. 2019;33(3):524–33. https://pubmed.ncbi.nlm.nih.gov/30575152/

5330

Baum L, Lam CWK, Cheung SKK, et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol. 2008;28(1):110–3. https://pubmed.ncbi.nlm.nih.gov/18204357/

5331

Ringman JM, Frautschy SA, Teng E, et al. Oral curcumin for Alzheimer’s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther. 2012;4(5):43. https://pubmed.ncbi.nlm.nih.gov/23107780/

5332

Gupta SC, Sung B, Kim JH, Prasad S, Li S, Aggarwal BB. Multitargeting by turmeric, the golden spice: from kitchen to clinic. Mol Nutr Food Res. 2013;57(9):1510–28. https://pubmed.ncbi.nlm.nih.gov/22887802/

5333

Ahmed T, Gilani AH. Therapeutic potential of turmeric in Alzheimer’s disease: curcumin or curcuminoids? Phytother Res. 2014;28(4):517–25. https://pubmed.ncbi.nlm.nih.gov/23873854/

5334

Hishikawa N, Takahashi Y, Amakusa Y, et al. Effects of turmeric on Alzheimer’s disease with behavioral and psychological symptoms of dementia. Ayu. 2012;33(4):499–504. https://pubmed.ncbi.nlm.nih.gov/23723666/

5335

Moazen-Zadeh E, Abbasi SH, Safi-Aghdam H, et al. Effects of saffron on cognition, anxiety, and depression in patients undergoing coronary artery bypass grafting: a randomized double-blind placebo-controlled trial. J Altern